Skip to main content

Table 1 Study characteristics and pooled HbA1c and TIR values

From: Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review

 

Type 1 diabetes

Type 2 diabetes

Participants (n)

2881

1823

Diabetes technology during lockdown

 CGM (n)

10

–

 FGM (n)

5

–

 HCL (n)

2

–

 SAP (n)

1

–

 Different types (n) (CGM, CSII, FGM, insulin pump)

5

–

 Telemedicinea (n)

–

5

 Not described (n)

2

3

Location

 Italy (n)

11

2

 Spain (n)

6

–

 Turkey (n)

–

2

 India (n)

4

3

 Greece (n)

1

1

 China (n)

1

–

 Israel (n)

1

–

 UK (n)

2

–

 Saudi Arabia (n)

1

–

 Japan (n)

1

–

Outcomesb

 Impact lockdown on HbA1c (%)

pooled HbA1c levels

Mean difference − 0.05 (95% CI − 0.31 to 0.21)

(based on n = 11 studies)

Mean difference + 0.14 (95% CI − 0.13 to 0.40)

(based on n = 8 studies)

Impact lockdown on time in range (TIR) (%), 70–180 mg/dl

pooled TIR values

Mean difference + 3.75 (95% CI 2.56 to 4.92)

(based on n = 18 studies)

N/A

  1. Italics indicate "pooled" parameters
  2. aTelemedical treatment not precisely described
  3. bCalculations of the outcomes that have been examined most often